CATX

← Markets

CATXPerspective Therapeutics, Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Tue, Aug 11
10:39 AMYahooPerspective Therapeutics's NET Program Data May Allow Phase 3 Trial Start, Value Inflection, RBC Says
Mon, Aug 10
3:22 PMYahooPerspective Therapeutics Provides Recent Business Highlights and Reports 2Q 2026 Results
Tue, Aug 4
8:40 AMYahooAre Medical Stocks Lagging Perspective Therapeutics, Inc. (CATX) This Year?
Fri, Jul 31
5:30 AMYahooPerspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results
Wed, Jul 29
8:55 AMYahooPerspective Therapeutics (CATX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Tue, Jul 28
5:30 AMYahooPerspective Therapeutics Receives European Orphan Medicinal Product Designation for [212Pb]VMT-α-NET in GEP-NETs
Fri, Jul 17
11:22 AMYahooPerspective Therapeutics Announces Acceptance of VMT-α-NET Data for Oral Presentation at the ESMO Congress 2026
Thu, Jul 16
8:40 AMYahooIs Perspective Therapeutics, Inc. (CATX) Stock Outpacing Its Medical Peers This Year?
Wed, Jul 8
5:30 AMYahooPerspective Therapeutics Appoints Paul Lyne, Ph.D., as Chief Science Officer; Co-Founder Michael K. Schultz, Ph.D., Transitions to Senior Scientific Advisor
Sun, Jul 5
5:08 PMYahooPerspective Therapeutics (CATX) Reports Encouraging Early Data Across Multiple Radiopharmaceutical Trials
Wed, Jun 3
1:06 PMproactiveinvestors.comPerspective Therapeutics doses first brain tumor patient in expanded radiopharmaceutical trial
5:30 AMYahooPerspective Therapeutics Expands Therapeutic Focus Areas; First Patient Dosed with [212Pb]VMT-α-NET in the Meningioma Cohort of a Phase 1/2a Study